Neuroscience
One of the number of media reports about today's Amyvid news:
- Amyvid Approval
From Pharmalot blog, a good read about the Amyvid approval decision: Should FDA Have Approved Lilly Alzheimer’s Agent? Pharmalot By Ed Silverman April 9th, 2012 // 11:23 am Read the full blog post...
- Clinical Trials: Solanezumab In Alzheimer's Disease
From Bloomberg: Eli Lilly Shares Rise on Alzheimer’s Drug Hopes By Drew Armstrong and Robert Langreth Dec 6, 2011 [snip] "Solanezumab is an antibody designed to clear protein fragments called beta amyloid that clutter the brains of patients with Alzheimer’s...
- Olfaction And Alzheimer's Disease
A new study has been funded to examine the use of olfactory testing in the earlier detection of Alzheimer's disease, one of my interests in neuropsychological assessment. The study is being funded and run is Australia. Here is a news report, from...
- Fda: Alzheimer's, Amyvid (florbetapir)
From MedPage Today: FDA Puts Early Alzheimer's Test on Hold By Peggy Peck, Executive Editor MedPage Today Published: March 18, 2011 [snip] "The FDA will not approve the novel contrast agent, florbetapir -- widely touted as a breakthrough for early...
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
From The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By THE ASSOCIATED PRESS Published: January 20, 2011 Filed at 5:40 p.m. ESTWASHINGTON (AP) — A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical...
Neuroscience
Alzheimer's Disease: Amyvid News
One of the number of media reports about today's Amyvid news:
Lilly fails to persuade Medicare to pay for Alzheimer's imaging drug
September 30, 2013
By Tracy Staton
FiercePharma
Read article
[snippet]
"The Centers for Medicare & Medicaid Services has handed down its final decision on Eli Lilly's Alzheimer's imaging agent Amyvid. The final answer, after appeals from Lilly and patient groups? No. Medicare won't pay for Amyvid-aided brain scans, not outside of clinical trials."
[snippet]
- Amyvid Approval
From Pharmalot blog, a good read about the Amyvid approval decision: Should FDA Have Approved Lilly Alzheimer’s Agent? Pharmalot By Ed Silverman April 9th, 2012 // 11:23 am Read the full blog post...
- Clinical Trials: Solanezumab In Alzheimer's Disease
From Bloomberg: Eli Lilly Shares Rise on Alzheimer’s Drug Hopes By Drew Armstrong and Robert Langreth Dec 6, 2011 [snip] "Solanezumab is an antibody designed to clear protein fragments called beta amyloid that clutter the brains of patients with Alzheimer’s...
- Olfaction And Alzheimer's Disease
A new study has been funded to examine the use of olfactory testing in the earlier detection of Alzheimer's disease, one of my interests in neuropsychological assessment. The study is being funded and run is Australia. Here is a news report, from...
- Fda: Alzheimer's, Amyvid (florbetapir)
From MedPage Today: FDA Puts Early Alzheimer's Test on Hold By Peggy Peck, Executive Editor MedPage Today Published: March 18, 2011 [snip] "The FDA will not approve the novel contrast agent, florbetapir -- widely touted as a breakthrough for early...
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
From The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By THE ASSOCIATED PRESS Published: January 20, 2011 Filed at 5:40 p.m. ESTWASHINGTON (AP) — A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical...